Physician profile
Supriya Varma
NPI 1689773731
$404.23
in general payments reported to CMS, 2019-2025
12 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $75.46 · 2021: $76.20 · 2022: $60.76 · 2023: $56.62 · 2024: $135.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $192.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $191.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Organon LLC | $86.84 | 2024 | |
| Abbvie INC. | $72.78 | 2019-2023 | Orilissa, Lo Loestrin Fe |
| Avion Pharmaceuticals | $51.92 | 2021-2022 | |
| Hologic Sales and Service, LLC | $44.73 | 2021-2024 | Aptima |
| Medicem INC. | $23.29 | 2021 | |
| Becton, Dickinson and Company | $22.43 | 2024 | Bd Max System, Bd Max Instrument |
| Daiichi Sankyo INC. | $22.22 | 2019 | |
| Abbott Laboratories | $22.07 | 2023 | Freestyle Libre 3 |
| Scynexis, INC. | $18.34 | 2022 | |
| Allergan, INC. | $14.29 | 2019 | |
| Therapeuticsmd, INC. | $14.03 | 2019 | |
| Coopersurgical, INC. | $11.29 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Supriya Varma listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.